Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

About The Journal Open Access

Journal of Cancer Immunology & Therapy

The journal welcomes submissions from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy.

Aims and Scope

Journal of Cancer Immunology & Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Journal of Cancer Immunology & Therapy organize a new platform for the researchers, scientists, scholars, students in this field to publish their research work & update the latest research information to the scientific community. Chief criteria for acceptance are scientific novelty and quality, originality, clarity, and conciseness with early online publication, regular podcasts and an immense archive collection.

You can submit your manuscript at https://www.scholarscentral.org/submissions/cancer-immunology-therapy.html as an email attachment to the e-mail id [email protected] or [email protected]

Please submit your manuscript to
[email protected]

Just Published Articles

Market Analysis February 03, 2020

P.1-2

J Cancer Immunol Ther: 3(1): 1-2

Market Analysis Report -2nd International Conference on Cancer Science and Cancer Therapy

Adrian Udrea

Editorial January 10, 2020

P.42-42

J Cancer Immunol Ther: 3(1): 42-42

OCM Announcement for 17th International Conference on Oncology Nursing and Cancer Care

Adrian Udrea